Condition: Mitral Regurgitation · Sponsor: LMU Klinikum
TENDER is a multicenter, single-device, retrospective and prospective, observational study to assess safety and efficacy of the Tendyne Mitral Valve System in a real-world population.
This description comes directly from the study's public registry record.
Joerg Hausleiter, MD · 0049894400 · joerg.hausleiter@med.uni-muenchen.de
Mirjam Wild, MD · mirjam.wild@insel.ch
Always discuss trial participation with your own doctor first.
| Universitaetsklinikum Linz | Linz, Austria | Recruiting |
| Universitaetsklinikum Wien | Vienna, Austria | Recruiting |
| UZ Leuven | Leuven, Belgium | Recruiting |
| CHU de Bordeaux | Bordeaux, France | Not Yet Recruiting |
| CHU de Lille | Lille, France | Recruiting |
| CHU Rennes | Rennes, France | Not Yet Recruiting |
| Clinique Pasteur | Toulouse, France | Recruiting |
| Herz- und Diabeteszentrum NRW | Bad Oeynhausen, Germany | Recruiting |
| Deutsches Herzzentrum Berlin | Berlin, Germany | Recruiting |
| Universitaetsklinikum Bonn | Bonn, Germany | Recruiting |
| Universitaetsklinikum Koeln | Cologne, Germany | Recruiting |
| Universitätsklinikum Frankfurt | Frankfurt, Germany | Recruiting |
+ 18 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04898335